<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are clonal <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> neutrophils have various abnormal functions which cause an increased risk of infective mortality </plain></SENT>
<SENT sid="1" pm="."><plain>We examined luminol-dependent chemiluminescence and cytoplasmic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> increase in order to characterize the mechanisms of a signalling defect in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> neutrophil respiratory burst </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, chemiluminescence stimulated with N-formyl-L-<z:chebi fb="0" ids="32648">methionyl</z:chebi>-L-leucil-<z:chebi fb="0" ids="17295,29997">L-phenylalanine</z:chebi> (<z:chebi fb="0" ids="53490">FMLP</z:chebi>) and <z:chebi fb="0" ids="22986">calcium ionophore</z:chebi> A23187 was defective (17.2 +/- 13.7 v 44.3 +/- 16.6, P = 0.001; 42.2 +/- 21.3 v 82.0 +/- 23.6, P &lt; 0.05, respectively), but <z:chebi fb="0" ids="8116">phorbol</z:chebi> 12-<z:chebi fb="0" ids="30807">myristate</z:chebi> 13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="1" ids="53780">PMA</z:chebi>) chemiluminescence was <z:mpath ids='MPATH_458'>normal</z:mpath> (73.4 +/- 26.9 v 79.5 +/- 23.8, P = 0.52) </plain></SENT>
<SENT sid="3" pm="."><plain>There were no statistical significances in cytoplasmic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> increase stimulated with <z:chebi fb="0" ids="53490">FMLP</z:chebi> and recombinant human interleukin-8 (rhIL-8) compared with controls (251.1 +/- 104.3 v 272.7 +/- 41.2, P = 0.295; 238.6 +/- 65.0 v 253.9 +/- 38.3, P = 0.567, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>Flow cytometric analysis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> neutrophils disclosed that most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients showed <z:mpath ids='MPATH_458'>normal</z:mpath> neutrophil cytoplasmic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> response to <z:chebi fb="0" ids="53490">FMLP</z:chebi> and rhIL-8 </plain></SENT>
<SENT sid="5" pm="."><plain>However, two patients with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts displayed a significant decrease of both chemiluminescence and cytoplasmic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> response to <z:chebi fb="0" ids="53490">FMLP</z:chebi>, and they also displayed low expression of <z:chebi fb="0" ids="53490">FMLP</z:chebi> receptor </plain></SENT>
<SENT sid="6" pm="."><plain>These data suggest that most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients have low <z:chebi fb="0" ids="53490">FMLP</z:chebi> chemiluminescence which is not due to a defect in the <z:chebi fb="0" ids="53490">FMLP</z:chebi> receptor </plain></SENT>
<SENT sid="7" pm="."><plain>It is proposed that defective <z:chebi fb="0" ids="53490">FMLP</z:chebi> chemiluminescence in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> results from a putative defect in protein kinase C- and Ca(2+)-independent cell-signalling mechanisms </plain></SENT>
<SENT sid="8" pm="."><plain>Only a small group of patients have numerical or structural defects in the <z:chebi fb="0" ids="53490">FMLP</z:chebi> receptor, causing significant decrease of neutrophil respiratory burst </plain></SENT>
</text></document>